Skip to main content
Clinical Trials/NCT06259500
NCT06259500
Active, not recruiting
Not Applicable

Generation and Analysis of Patient-derived Stem Cell Models of Hypothalamic Neurons and Microglia in Anorexia Nervosa

Karolinska Institutet1 site in 1 country20 target enrollmentAugust 25, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anorexia Nervosa
Sponsor
Karolinska Institutet
Enrollment
20
Locations
1
Primary Endpoint
Arcuate neuron function and transcriptomic profiling
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

Experimental and genetic data, as well as brain imaging, support a role of the hypothalamic Arcuate nucleus neurons and their communication with surrounding microglia in anorectic conditions, but it has until recently not been possible to explore these cells at a molecular level in anorexia nervosa (AN) patients. This attributed to the obvious lack of valid tissue and non-invasive imaging techniques of high enough resolution. Stem cell models have evolved as a useful tool for the exploration of other neuropsychiatric disorders with a comparably high genetic contribution as AN. The investigators will here use patient-derived induced pluripotent stem cells (iPSCs) to profile Arc neurons and peripheral blood mononuclear cell (PBMC) derived microglia in AN, thus defining molecules to explore as drug targets.

Registry
clinicaltrials.gov
Start Date
August 25, 2022
End Date
December 31, 2026
Last Updated
10 months ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ida AK Nilsson

Associate Professor

Karolinska Institutet

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Arcuate neuron function and transcriptomic profiling

Time Frame: 2026

Electrical activity, transmitter release and whole transcriptomic profiling of iPSC derived Arcuate neurons, anorexia nervosa vs healthy controls

Microglia function and transcriptomic profiling

Time Frame: 2025

phagocytic and immune activation capacity and whole transcriptomic profiling, anorexia nervosa vs healthy controls

Study Sites (1)

Loading locations...

Similar Trials